The common goal of the more than 400 TAP R&D professionals is to help improve the health and quality of life of our patients through good science, innovative technology, and a commitment to quality.

TAP explores new areas of medicine to bring the power of next-generation science to bear on existing health conditions. All of our drug compounds undergo a thorough pre-clinical assessment to determine the initial proof of safety. Then clinical trials may be conducted with patients. These studies allow TAP to demonstrate the safety of the drug and its efficacy in treating patients with the target medical condition.

TAP R&D is an industry leader in employing innovative technology for clinical research. Better access to information supports real-time decision-making. However, even in e-R&D, good science is more about people than technology.

TAP R&D and our collaborative partners adhere to Good Clinical Practices (GCP), federal requirements, and international guidelines in conducting clinical trials to protect the rights and welfare of our study participants and the validity of the study data. TAP also voluntarily adopted the Pharmaceutical Research and Manufacturers of America (PhRMA) code for integrity, compliance and social responsibility. TAP and our partners also follow Good Manufacturing and Good Laboratory Practices (GMP and GLP) as well.

Our clinical research philosophy revolves around core values: a commitment to our patients, use of innovative technology, developing a scientific vision, and dedication to quality.

Registration of Clinical Trials
TAP is committed to communicating clinical trial information for all TAP-sponsored hypothesis-testing trials initiated on or after October 15, 2002. TAP-sponsored clinical trials are registered on a publicly accessible website in accordance with state and federal guidelines, PhRMA principles and the International Committee of Medical Journal Editor (ICMJE)guidelines. Clinical trial information including but not limited to the purpose, enrollment criteria, study locations and contact information are registered on the National Library of Medicine’s website, www.clinicaltrials.gov before enrollment of the first patient.

Reporting Clinical Trial Results
TAP publicly communicates scientifically valid results of TAP-sponsored clinical trials, regardless of outcome, by posting the primary peer-reviewed publication of original research or non-promotional synopses of study results on the public website, www.clinicalstudyresults.org.

TAP maintains the highest ethical standards to ensure quality information is communicated by following national and international publication guidelines including Good Publication Practice Guidelines for pharmaceutical companies, and ICMJE and PhRMA guidelines.